A Phase Ib/II Randomized Clinical Trial of Oleclumab with or without Durvalumab plus Chemotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma
一项针对转移性胰腺导管腺癌患者的Ib/II期随机临床试验,评估奥莱克鲁单抗联合或不联合度伐利尤单抗及化疗的疗效
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-24-0499
Coveler, Andrew L; Reilley, Matthew J; Zalupski, Mark; Macarulla, Teresa; Fountzilas, Christos; Ponz-Sarvisé, Mariano; Nagrial, Adnan; Uboha, Nataliya V; Frentzas, Sophia; Overman, Michael; Noonan, Anne; Messersmith, Wells A; Pavlakis, Nick; Mettu, Niharika B; Bisha, Ina; Wang, Ying; Smith, Paul; Murtomaki, Elina; Bielska, Agata A; Bragulat, Veronique; Cooper, Zachary A; Kumar, Rakesh; Spigel, David R